Pioneering leader’s Senda Bio secures $123M for new ‘programmable drugs’ – MedCity News
Senda Biosciences set out to overcome challenges in drug delivery. Her research has led the startup to nanoparticles, which executives say offer a path to “programmable drugs” that can target…